— Know what they know.
Not Investment Advice

WST NYSE

West Pharmaceutical Services, Inc.
1W: +2.4% 1M: +6.0% 3M: +18.0% YTD: +44.2% 1Y: +34.0% 3Y: +10.2% 5Y: -3.6%
$398.29
+3.56 (+0.90%)
 
Weekly Expected Move ±2.9%
$370 $381 $392 $403 $415
NYSE · Healthcare · Medical - Instruments & Supplies · Tech Score Strong Buy · Power 71 · $28.0B mcap · 70M float · 0.940% daily turnover · Short 52% of daily vol
Credit Risk of going bust: lower than 93% of companies Debt: 1.1% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.34 (down 99.9%), West Pharmaceutical Services, Inc. would be worth roughly what it owes.
Total debt $312.1M against a stock market value of $28.03B.
Distance to default 16.53 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $166.5M (short-term plus half of long-term), stock volatility 31.2%; Altman Z 18.79. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
54.5 / 100
NoneWeakNarrowWide
Primary source: Efficient Scale  ·  ROIC: 19.0%  ·  5Y Avg: 21.4%
Cost Advantage
80
Intangibles
42
Switching Cost
38
Network Effect
40
Scale ★
83
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. WST shows a Weak competitive edge (54.5/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Efficient Scale. ROIC of 19.0% confirms the company is generating returns well above its cost of capital — a hallmark of durable competitive advantages.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$400
Low
$420
Avg Target
$440
High
Based on 4 analysts since Jul 23, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 14Hold: 2Sell: 1Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$418.33
Analysts3
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-10-07 Barclays Luke Sergott $400 $440 +40 +18.1% $372.64
2026-09-22 Morgan Stanley Kallum Titchmarsh $365 $400 +35 +10.6% $361.73
2026-09-09 UBS — $340 $415 +75 +22.8% $338.06
2026-07-27 Evercore ISI — $410 $425 +15 +27.6% $333.12
2026-07-13 BNP Paribas — Initiated $447 — +26.4% $353.71
2026-07-09 Morgan Stanley — $315 $365 +50 +3.2% $353.68
2026-07-06 Evercore ISI Daniel Markowitz $320 $410 +90 +14.1% $359.27
2026-07-02 KeyBanc — Initiated $390 — +6.8% $365.00
2026-06-09 Barclays Luke Sergott $310 $400 +90 +25.1% $319.75
2026-04-27 Morgan Stanley — $285 $315 +30 +2.8% $306.39
2026-04-27 Barclays — $265 $310 +45 +1.3% $306.16
2026-02-13 UBS Dan Leonard $355 $340 -15 +37.9% $246.60
2026-02-13 Deutsche Bank — $345 $315 -30 +27.3% $247.49
2026-02-13 Barclays Luke Sergott $325 $265 -60 +8.8% $243.61
2026-02-10 Jefferies David Windley $393 $295 -98 +18.0% $249.97
2026-02-03 Evercore ISI Daniel Markowitz $390 $320 -70 +34.5% $237.88
2025-12-01 Morgan Stanley — Initiated $285 — +4.0% $274.14
2025-10-27 Barclays — $275 $325 +50 +10.7% $293.62
2025-10-24 UBS Dan Leonard $250 $355 +105 +15.5% $307.25
2025-10-24 Deutsche Bank Justin Bowers $250 $345 +95 +13.2% $304.74
2025-10-23 Evercore ISI Daniel Markowitz $350 $390 +40 +26.1% $309.28
2025-10-07 Evercore ISI — Initiated $350 — +30.6% $268.07
2025-10-02 Barclays — $245 $275 +30 +1.3% $271.42
2025-09-15 Redburn Partners Jamie Clark Initiated $311 — +20.8% $257.53
2025-06-24 Barclays Luke Sergott Initiated $245 — +10.0% $222.68
2024-11-19 Jefferies David Windley $536 $393 -143 +36.5% $287.85
2024-02-06 Jefferies David Windley Initiated $536 — +29.8% $413.00
2022-12-13 Deutsche Bank — Initiated $250 — -0.8% $251.90
2022-11-30 UBS — Initiated $250 — +12.2% $222.84

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

B+
Oct 27, 2026
DCF
3
ROE
5
ROA
5
D/E
3
P/E
1
P/B
1
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. WST receives an overall rating of B+. Strongest factors: ROE (5/5), ROA (5/5). Areas of concern: P/E (1/5), P/B (1/5).
Rating Change History
DateFromTo
2026-10-12 B B+
2026-10-01 B+ B
2026-08-04 B B+
2026-07-30 B+ B
2026-04-27 B B+
2026-02-17 C- B
2026-02-12 B C-
2026-02-02 B+ B
2026-01-03 B B+

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 72 Grade A+
Profitability
67
Balance Sheet
90
Earnings Quality
72
Growth
61
Value
41
Momentum
84
Safety
100
Cash Flow
73
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. WST scores highest in Safety (100/100) and lowest in Value (41/100). An overall grade of A+ places WST among the highest-quality companies in its peer group.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
17.45
Safe Zone
Piotroski F-Score
9/9
✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
Beneish M-Score
-3.79
Unlikely Manipulator
Ohlson O-Score
-10.58
Bankruptcy prob: 0.0%
Low Risk
Credit Rating
AAA
Score: 95.7/100
Trend: Stable
Earnings Quality
100/100
OCF/NI: 1.17x
Accruals: -2.4%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. WST scores 17.45, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. WST scores 9/9, signaling strong financial health across all three dimensions. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. WST's score of -3.79 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. WST's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. WST receives an estimated rating of AAA (score: 95.7/100), with a stable trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). WST's score of 100/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
50.61x
PEG
2.96x
P/S
8.43x
P/B
9.43x
P/FCF
58.59x
P/OCF
38.65x
EV/EBITDA
29.27x
EV/Revenue
7.66x
EV/EBIT
36.94x
EV/FCF
58.30x
Earnings Yield
2.21%
FCF Yield
1.71%
Shareholder Yield
0.24%
Graham Number
$86.46
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 50.6x earnings, WST is priced for high growth expectations. Graham's intrinsic value formula yields $86.46 per share, 361% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.807
NI / EBT
×
Interest Burden
1.015
EBT / EBIT
×
EBIT Margin
0.207
EBIT / Rev
×
Asset Turnover
0.829
Rev / Assets
×
Equity Multiplier
1.356
Assets / Equity
=
ROE
19.1%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. WST's ROE of 19.1% is driven by Asset Turnover (0.829), indicating efficient use of assets to generate revenue.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
4.82%
Fair P/E
18.14x
Intrinsic Value
$143.73
Price/Value
2.50x
Margin of Safety
-149.78%
Premium
149.78%
Assessment
Neutral
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with WST's realized 4.8% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. WST trades at a 150% premium to its adjusted intrinsic value of $143.73, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 18.1x compares to the current market P/E of 50.6x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$398.20
Median 1Y
$424.58
5th Pctile
$236.02
95th Pctile
$768.07
Ann. Volatility
39.4%
Analyst Target
$418.33
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Robert W. McMahon
SVP, Chief Financial Officer
$292,308 $5,836,414 $11,804,963
Eric M. Green
President and CEO, Chair of Board
$1,177,290 $3,327,048 $7,190,876
Shane A. Campbell
SVP, Chief Proprietary Segment Officer
$369,231 $1,193,204 $2,402,998
Bernard J. Birkett
Former SVP, Chief Financial Officer
$637,808 $1,101,209 $2,143,249
Annette F. Favorite
SVP, Chief Human Resources Officer
$450,000 $342,875 $1,389,925
Kimberly B. MacKay
Former SVP, General Counsel and Secretary
$487,000 $318,188 $1,258,170

CEO Pay Ratio

198:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $7,190,876
Avg Employee Cost (SGA/emp): $36,398
Employees: 10,800

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
10,800
+1.9% YoY
Revenue / Employee
$284,602
Rev: $3,073,700,000
Profit / Employee
$45,713
NI: $493,700,000
SGA / Employee
$36,398
Avg labor cost proxy
R&D / Employee
$6,880
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE 31.2% 31.6% 32.9% 30.8% 27.0% 23.3% 21.6% 20.1% 21.0% 21.3% 20.8% 19.7% 17.8% 17.7% 17.4% 17.7% 16.9% 16.9% 19.1% 19.1% 19.09%
ROA 21.4% 21.7% 22.7% 21.8% 19.5% 16.9% 15.7% 14.8% 15.8% 15.9% 15.5% 14.7% 13.4% 13.2% 12.9% 13.1% 12.6% 12.5% 14.0% 14.1% 14.07%
ROIC 33.0% 34.2% 33.4% 32.7% 32.1% 30.1% 27.7% 25.8% 25.7% 25.4% 23.6% 21.2% 19.2% 19.6% 18.6% 18.3% 18.5% 17.7% 18.9% 19.0% 19.01%
ROCE 26.7% 27.8% 28.4% 28.1% 25.9% 22.2% 20.6% 19.5% 20.7% 22.4% 22.9% 21.7% 18.8% 19.0% 18.5% 17.9% 17.5% 16.7% 19.4% 20.1% 20.07%
Gross Margin 40.8% 40.1% 39.6% 41.4% 39.0% 37.2% 37.8% 38.7% 38.7% 38.1% 33.3% 32.9% 35.5% 36.7% 33.3% 35.7% 36.5% 37.8% 35.1% 37.7% 37.74%
Operating Margin 26.0% 24.8% 26.0% 29.0% 27.3% 22.8% 23.4% 24.8% 25.6% 23.3% 18.3% 18.6% 22.5% 22.8% 18.4% 20.6% 21.6% 19.5% 21.0% 20.5% 20.53%
Net Margin 24.9% 20.3% 24.1% 24.4% 17.6% 14.5% 19.6% 20.6% 21.6% 18.7% 16.6% 15.9% 18.2% 17.4% 12.9% 17.2% 17.4% 16.4% 16.4% 17.7% 17.65%
EBITDA Margin 30.1% 30.1% 30.4% 33.6% 24.5% 22.8% 26.8% 29.4% 30.2% 28.0% 23.7% 24.1% 27.5% 27.5% 21.6% 25.9% 27.0% 26.0% 25.9% 25.8% 25.83%
FCF Margin 12.7% 11.7% 13.3% 13.7% 13.3% 15.2% 14.2% 13.9% 14.4% 14.1% 13.2% 12.4% 11.2% 9.6% 10.6% 11.6% 12.6% 15.3% 14.2% 13.1% 13.13%
OCF Margin 21.3% 20.6% 22.5% 23.1% 22.5% 25.1% 24.7% 24.7% 26.3% 26.3% 25.8% 26.2% 24.4% 22.6% 23.0% 22.9% 23.0% 24.6% 22.2% 19.9% 19.91%
ROE 3Y Avg snapshot only 18.64%
ROE 5Y Avg snapshot only 20.62%
ROA 3Y Avg snapshot only 13.75%
ROIC 3Y Avg snapshot only 16.60%
ROIC Economic snapshot only 16.84%
Cash ROA snapshot only 16.24%
Cash ROIC snapshot only 23.10%
CROIC snapshot only 15.24%
NOPAT Margin snapshot only 16.38%
Pretax Margin snapshot only 21.03%
R&D / Revenue snapshot only 2.24%
SGA / Revenue snapshot only 12.82%
SBC / Revenue snapshot only 0.98%
Valuation
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio 52.11 53.59 45.16 33.12 29.28 30.13 47.16 55.22 50.19 44.25 51.44 46.04 43.93 48.84 34.89 32.61 38.76 40.52 33.44 45.31 50.609
P/S Ratio 11.90 12.53 10.73 7.76 6.35 6.12 9.03 10.00 9.60 8.90 9.99 8.40 7.63 8.32 5.63 5.37 6.32 6.51 5.63 7.69 8.426
P/B Ratio 14.49 15.18 13.29 9.36 7.47 6.57 9.38 10.43 9.79 9.12 10.91 9.38 7.97 8.97 6.08 5.43 6.24 6.30 6.07 8.56 9.430
P/FCF 93.58 107.27 80.91 56.55 47.61 40.17 63.51 72.19 66.85 63.35 75.76 67.67 68.24 87.06 53.11 46.23 50.27 42.66 39.62 58.59 58.587
P/OCF 55.81 60.72 47.81 33.63 28.23 24.38 36.63 40.52 36.55 33.82 38.66 32.12 31.24 36.83 24.53 23.50 27.47 26.50 25.37 38.65 38.654
EV/EBITDA 39.11 39.82 34.24 24.51 20.83 21.14 32.64 37.91 34.34 30.47 35.45 31.44 29.24 32.07 22.16 20.64 24.25 25.29 21.27 29.27 29.266
EV/Revenue 11.76 12.37 10.62 7.63 6.20 5.92 8.84 9.83 9.39 8.72 9.89 8.35 7.57 8.26 5.59 5.30 6.21 6.39 5.57 7.66 7.658
EV/EBIT 45.71 46.25 39.70 28.38 24.31 24.85 38.72 45.70 41.16 36.38 42.86 38.86 36.66 40.53 28.36 26.24 30.85 32.46 26.87 36.94 36.939
EV/FCF 92.48 105.94 80.03 55.59 46.51 38.86 62.11 70.97 65.44 62.04 75.00 67.29 67.66 86.41 52.78 45.63 49.39 41.86 39.17 58.30 58.304
Earnings Yield 1.9% 1.9% 2.2% 3.0% 3.4% 3.3% 2.1% 1.8% 2.0% 2.3% 1.9% 2.2% 2.3% 2.0% 2.9% 3.1% 2.6% 2.5% 3.0% 2.2% 2.21%
FCF Yield 1.1% 0.9% 1.2% 1.8% 2.1% 2.5% 1.6% 1.4% 1.5% 1.6% 1.3% 1.5% 1.5% 1.1% 1.9% 2.2% 2.0% 2.3% 2.5% 1.7% 1.71%
PEG Ratio snapshot only 2.957
Price/Tangible Book snapshot only 8.903
EV/OCF snapshot only 38.467
EV/Gross Profit snapshot only 20.828
Acquirers Multiple snapshot only 37.106
Shareholder Yield snapshot only 0.24%
Graham Number snapshot only $86.46
Leverage & Solvency
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio 2.86 2.93 2.89 3.13 3.80 3.70 3.62 3.66 3.70 2.88 2.61 2.34 3.00 2.79 2.77 2.78 2.87 3.02 2.71 2.82 2.822
Quick Ratio 2.23 2.30 2.18 2.41 2.89 2.90 2.79 2.78 2.89 2.24 1.95 1.68 2.23 2.11 2.03 2.08 2.18 2.34 2.04 2.12 2.123
Debt/Equity 0.14 0.14 0.14 0.14 0.12 0.12 0.11 0.11 0.11 0.11 0.11 0.12 0.11 0.11 0.11 0.10 0.10 0.13 0.11 0.10 0.104
Net Debt/Equity -0.17 -0.19 -0.14 -0.16 -0.17 -0.21 -0.21 -0.18 -0.21 -0.19 -0.11 -0.05 -0.07 -0.07 -0.04 -0.07 -0.11 -0.12 -0.07 -0.04 -0.041
Debt/Assets 0.10 0.10 0.10 0.10 0.09 0.09 0.08 0.08 0.08 0.08 0.09 0.09 0.08 0.08 0.08 0.08 0.07 0.10 0.08 0.08 0.077
Debt/EBITDA 0.39 0.37 0.37 0.37 0.35 0.39 0.40 0.42 0.38 0.37 0.38 0.41 0.41 0.41 0.41 0.40 0.39 0.54 0.37 0.36 0.359
Net Debt/EBITDA -0.46 -0.50 -0.38 -0.42 -0.50 -0.71 -0.73 -0.65 -0.74 -0.65 -0.36 -0.18 -0.25 -0.24 -0.14 -0.27 -0.43 -0.48 -0.24 -0.14 -0.142
Interest Coverage 86.26 90.15 88.52 90.38 81.52 90.41 85.42 72.49 71.81 80.32 83.41 88.33 123.67 159.24 219.69 498.42 1011.67 1007.67 3338.00 6896.00 6896.000
Equity Multiplier 1.43 1.42 1.42 1.39 1.34 1.35 1.34 1.34 1.31 1.33 1.34 1.35 1.34 1.36 1.35 1.35 1.35 1.34 1.37 1.36 1.363
Cash Ratio snapshot only 0.680
Debt Service Coverage snapshot only 8704.000
Cash to Debt snapshot only 1.396
FCF to Debt snapshot only 1.400
Defensive Interval snapshot only 781.6 days
Efficiency & Turnover
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 0.94 0.93 0.95 0.93 0.90 0.83 0.82 0.81 0.83 0.79 0.80 0.80 0.77 0.77 0.80 0.80 0.78 0.78 0.83 0.83 0.829
Inventory Turnover 4.91 4.75 4.67 4.60 4.54 4.41 4.08 4.11 4.29 4.28 4.19 4.25 4.49 4.66 4.62 4.56 4.63 4.80 4.88 4.84 4.844
Receivables Turnover 6.32 6.48 5.97 5.80 6.04 5.79 5.70 5.39 5.83 5.79 5.65 5.68 5.51 5.43 5.42 5.58 5.25 5.46 5.24 5.14 5.140
Payables Turnover 8.21 7.46 7.50 8.19 8.78 7.82 7.31 8.09 8.86 7.94 7.75 8.59 8.42 7.85 8.08 8.49 8.10 7.99 8.54 8.56 8.556
DSO 58 56 61 63 60 63 64 68 63 63 65 64 66 67 67 65 70 67 70 71 71.0 days
DIO 74 77 78 79 80 83 89 89 85 85 87 86 81 78 79 80 79 76 75 75 75.4 days
DPO 44 49 49 45 42 47 50 45 41 46 47 42 43 47 45 43 45 46 43 43 42.7 days
Cash Conversion Cycle 88 84 91 98 99 99 104 111 107 102 105 108 104 99 101 103 103 97 102 104 103.7 days
Fixed Asset Turnover snapshot only 0.992
Operating Cycle snapshot only 146.4 days
Cash Velocity snapshot only 7.633
Capital Intensity snapshot only 1.225
Growth (YoY)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 31.4% 31.9% 23.8% 16.0% 8.4% 2.0% 0.1% -2.1% 0.7% 2.2% 1.6% 0.4% -1.7% -1.9% -1.1% 2.9% 4.9% 6.3% 11.2% 12.4% 12.39%
Net Income 96.5% 91.2% 61.8% 32.0% 3.0% -11.5% -19.3% -24.3% -11.3% 1.3% 3.0% 1.2% -10.7% -17.0% -17.8% -7.1% -1.6% 0.2% 16.2% 15.8% 15.83%
EPS 96.0% 90.4% 61.3% 31.9% 3.4% -10.5% -19.0% -23.9% -10.8% 2.1% 4.9% 3.5% -8.4% -15.5% -16.4% -5.9% -0.6% 1.6% 17.1% 18.3% 18.27%
FCF 25.4% 10.9% 24.4% 39.7% 13.7% 32.9% 7.3% -1.2% 8.3% -5.7% -5.8% -10.0% -23.4% -33.3% -20.5% -3.7% 17.9% 69.6% 49.2% 27.0% 27.01%
EBITDA 68.6% 69.5% 46.3% 26.1% 7.3% -8.2% -12.6% -18.4% -7.6% 4.5% 4.7% 2.9% -7.0% -11.8% -10.5% -0.5% 3.7% 4.2% 15.4% 14.5% 14.47%
Op. Income 84.2% 78.9% 47.1% 25.2% 12.0% 0.7% -2.7% -9.1% -9.2% -5.7% -8.7% -12.0% -15.8% -16.8% -11.6% 0.9% 5.8% 3.5% 11.4% 9.8% 9.84%
OCF Growth snapshot only -2.14%
Asset Growth snapshot only 3.13%
Equity Growth snapshot only 2.09%
Debt Growth snapshot only 2.90%
Shares Change snapshot only -2.06%
Dividend Growth snapshot only 6.01%
Growth (CAGR)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 3Y 16.1% 18.1% 18.2% 18.3% 17.5% 16.1% 15.1% 13.7% 12.7% 11.2% 8.0% 4.5% 2.4% 0.7% 0.2% 0.4% 1.3% 2.1% 3.8% 5.1% 5.11%
Revenue 5Y 12.5% 13.4% 13.4% 13.6% 13.2% 12.5% 12.1% 11.3% 11.3% 11.4% 10.9% 10.2% 9.9% 9.4% 8.9% 8.7% 8.1% 7.4% 6.7% 5.7% 5.68%
EPS 3Y 58.8% 46.8% 45.8% 43.7% 39.9% 34.4% 28.3% 22.0% 21.8% 20.3% 11.1% 1.3% -5.5% -8.3% -10.8% -9.5% -6.7% -4.3% 0.9% 4.8% 4.82%
EPS 5Y 34.4% 35.2% 29.9% 31.2% 27.2% 31.7% 33.3% 28.3% 29.8% 23.6% 21.4% 18.5% 17.5% 15.9% 13.1% 12.1% 10.5% 8.3% 6.1% 2.9% 2.93%
Net Income 3Y 59.0% 47.3% 46.3% 44.2% 40.0% 34.3% 28.4% 22.0% 21.5% 19.7% 10.4% 0.4% -6.6% -9.4% -11.9% -10.7% -8.0% -5.5% -0.6% 2.9% 2.88%
Net Income 5Y 34.8% 35.8% 30.3% 31.2% 27.1% 31.6% 33.4% 28.5% 29.7% 23.5% 21.1% 18.1% 16.8% 15.3% 12.4% 11.3% 9.5% 7.4% 5.1% 1.7% 1.70%
EBITDA 3Y 32.7% 35.5% 34.3% 32.8% 30.2% 26.1% 22.9% 18.9% 18.7% 17.6% 10.2% 1.9% -2.6% -5.4% -6.5% -5.8% -3.7% -1.3% 2.6% 5.4% 5.43%
EBITDA 5Y 21.4% 22.9% 22.8% 24.7% 22.3% 19.9% 19.3% 16.6% 18.3% 19.0% 17.2% 14.5% 13.7% 13.1% 11.7% 11.4% 10.1% 8.4% 6.7% 3.8% 3.82%
Gross Profit 3Y 26.1% 28.9% 28.5% 27.5% 25.9% 23.1% 21.2% 18.0% 16.3% 14.0% 7.9% 1.3% -2.6% -5.0% -5.3% -4.1% -2.7% -1.0% 1.3% 3.8% 3.79%
Gross Profit 5Y 17.0% 18.5% 18.2% 18.7% 18.0% 17.1% 16.8% 15.5% 15.5% 15.7% 14.4% 12.5% 11.5% 10.5% 9.8% 9.4% 8.6% 7.6% 6.1% 4.3% 4.29%
Op. Income 3Y 47.3% 45.5% 42.4% 39.3% 36.6% 36.7% 33.2% 26.9% 23.3% 19.3% 9.3% 0.0% -5.0% -7.6% -7.7% -6.9% -6.8% -6.7% -3.5% -0.8% -0.84%
Op. Income 5Y 29.7% 30.6% 27.0% 28.3% 29.4% 28.0% 28.9% 27.5% 26.6% 24.0% 20.7% 16.7% 14.3% 14.9% 13.8% 12.7% 10.8% 7.9% 5.2% 2.1% 2.08%
FCF 3Y 21.0% 21.6% 27.2% 26.0% 21.7% 22.2% 18.4% 12.7% 15.6% 11.6% 7.9% 7.5% -1.9% -5.8% -7.0% -5.0% -0.8% 2.2% 3.8% 3.3% 3.26%
FCF 5Y 48.0% 46.4% 41.1% 37.1% 29.9% 27.1% 19.8% 18.2% 16.9% 17.6% 15.8% 12.2% 8.4% 2.8% 4.4% 4.4% 6.9% 9.5% 8.3% 8.7% 8.74%
OCF 3Y 24.4% 26.5% 30.5% 29.0% 25.1% 25.4% 23.6% 19.0% 21.3% 18.0% 14.5% 14.6% 7.1% 3.8% 0.9% 0.1% 2.0% 1.4% 0.2% -2.2% -2.16%
OCF 5Y 21.5% 21.6% 22.2% 22.4% 20.9% 22.4% 19.8% 20.0% 20.9% 21.9% 21.0% 19.1% 16.0% 12.2% 12.0% 10.0% 10.0% 9.8% 7.2% 5.8% 5.76%
Assets 3Y 17.3% 27.7% 17.4% 16.6% 15.1% 15.6% 18.3% 15.3% 13.3% 11.1% 9.6% 6.0% 5.4% 3.2% 3.2% 5.5% 7.4% 5.7% 3.3% 3.6% 3.57%
Assets 5Y 12.6% 14.1% 13.7% 12.8% 11.4% 14.2% 14.8% 14.4% 14.0% 19.2% 12.1% 10.4% 11.1% 9.2% 10.0% 10.6% 9.7% 8.9% 8.4% 6.8% 6.80%
Equity 3Y 17.7% 18.7% 19.2% 18.8% 18.4% 19.5% 23.0% 19.6% 18.6% 15.8% 13.6% 8.2% 7.7% 4.7% 4.9% 6.5% 7.3% 5.8% 2.5% 2.9% 2.87%
Book Value 3Y 17.5% 18.2% 18.8% 18.5% 18.3% 19.6% 22.9% 19.6% 18.9% 16.4% 14.3% 9.2% 9.0% 6.0% 6.3% 7.9% 8.7% 7.1% 4.0% 4.8% 4.81%
Dividend 3Y 2.0% 1.6% 1.7% 1.5% 1.8% 2.0% 1.7% 2.2% 2.1% 2.3% 2.4% 2.3% 2.5% 2.4% 2.5% 2.5% 2.6% 2.5% 2.7% 3.2% 3.16%
Growth Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability 0.81 0.82 0.86 0.88 0.90 0.90 0.92 0.90 0.92 0.90 0.89 0.81 0.77 0.71 0.68 0.68 0.73 0.78 0.87 0.90 0.897
Earnings Stability 0.72 0.77 0.79 0.86 0.84 0.85 0.85 0.79 0.81 0.78 0.70 0.54 0.46 0.40 0.24 0.13 0.05 0.01 0.00 0.07 0.074
Margin Stability 0.90 0.89 0.89 0.89 0.89 0.89 0.89 0.90 0.90 0.90 0.91 0.91 0.91 0.91 0.92 0.93 0.94 0.95 0.96 0.96 0.956
Rev. Growth Consistency 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.00 1.00 1.00 1.00 0.50 0.00 0.00 0.00 1.00 0.50 0.50 0.50 1.00 1.000
Earn. Growth Consistency 1.00 1.00 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.500
FCF Positive Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Earnings Persistence 0.50 0.50 0.50 0.87 0.99 0.95 0.92 0.90 0.95 0.99 0.99 1.00 0.96 0.93 0.93 0.97 0.99 1.00 0.94 0.94 0.937
Earnings Smoothness 0.35 0.37 0.53 0.72 0.97 0.88 0.79 0.72 0.88 0.99 0.97 0.99 0.89 0.81 0.80 0.93 0.98 1.00 0.85 0.85 0.853
ROE Trend 0.11 0.11 0.09 0.07 0.03 -0.02 -0.06 -0.08 -0.07 -0.04 -0.03 -0.03 -0.04 -0.03 -0.03 -0.03 -0.03 -0.04 -0.01 0.00 0.004
Gross Margin Trend 0.07 0.07 0.06 0.04 0.02 0.01 -0.00 -0.02 -0.02 -0.02 -0.03 -0.04 -0.04 -0.04 -0.03 -0.02 -0.01 -0.01 0.00 0.01 0.012
FCF Margin Trend 0.00 -0.02 0.00 0.01 0.00 0.02 0.01 0.01 0.01 0.01 -0.01 -0.01 -0.03 -0.05 -0.03 -0.02 -0.00 0.03 0.02 0.01 0.011
Sustainable Growth Rate 28.7% 29.2% 30.4% 28.4% 24.7% 21.2% 19.5% 17.9% 18.8% 19.3% 18.7% 17.5% 15.7% 15.6% 15.2% 15.5% 14.9% 14.8% 17.0% 17.0% 16.98%
Internal Growth Rate 24.4% 25.0% 26.5% 25.2% 21.8% 18.1% 16.5% 15.2% 16.6% 16.8% 16.2% 15.0% 13.5% 13.1% 12.7% 13.0% 12.5% 12.3% 14.2% 14.3% 14.31%
Cash Flow Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income 0.93 0.88 0.94 0.98 1.04 1.24 1.29 1.36 1.37 1.31 1.33 1.43 1.41 1.33 1.42 1.39 1.41 1.53 1.32 1.17 1.172
FCF/OCF 0.60 0.57 0.59 0.59 0.59 0.61 0.58 0.56 0.55 0.53 0.51 0.47 0.46 0.42 0.46 0.51 0.55 0.62 0.64 0.66 0.660
FCF/Net Income snapshot only 0.773
OCF/EBITDA snapshot only 0.761
CapEx/Revenue 8.6% 9.0% 9.2% 9.4% 9.2% 9.9% 10.4% 10.8% 11.9% 12.3% 12.6% 13.7% 13.2% 13.0% 12.4% 11.2% 10.4% 9.3% 8.0% 6.8% 6.77%
CapEx/Depreciation snapshot only 1.246
Accruals Ratio 0.01 0.03 0.01 0.00 -0.01 -0.04 -0.05 -0.05 -0.06 -0.05 -0.05 -0.06 -0.05 -0.04 -0.05 -0.05 -0.05 -0.07 -0.04 -0.02 -0.024
Sloan Accruals snapshot only -0.022
Cash Flow Adequacy snapshot only 2.302
Earnings Quality Score snapshot only 1.000
Dividends & Buybacks
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield 0.2% 0.1% 0.2% 0.2% 0.3% 0.3% 0.2% 0.2% 0.2% 0.2% 0.2% 0.2% 0.3% 0.2% 0.4% 0.4% 0.3% 0.3% 0.3% 0.2% 0.22%
Dividend/Share $0.66 $0.67 $0.68 $0.69 $0.70 $0.72 $0.72 $0.74 $0.75 $0.76 $0.78 $0.79 $0.80 $0.80 $0.82 $0.83 $0.83 $0.84 $0.85 $0.88 $0.88
Payout Ratio 8.2% 7.7% 7.6% 7.6% 8.5% 9.2% 9.9% 10.8% 10.1% 9.6% 10.1% 11.1% 11.7% 12.0% 12.8% 12.3% 12.3% 12.4% 11.4% 11.0% 11.05%
FCF Payout Ratio 14.8% 15.5% 13.6% 13.1% 13.7% 12.3% 13.4% 14.1% 13.4% 13.8% 14.9% 16.3% 18.2% 21.4% 19.4% 17.5% 16.0% 13.1% 13.5% 14.3% 14.28%
Total Payout Ratio 33.6% 30.7% 32.0% 36.1% 43.7% 47.2% 33.1% 63.5% 59.0% 85.6% 1.2% 1.4% 1.5% 1.3% 1.0% 62.3% 51.2% 40.1% 66.4% 11.1% 11.10%
Div. Increase Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Chowder Number 0.07 0.06 0.06 0.06 0.06 0.06 0.06 0.07 0.06 0.06 0.05 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.041
Buyback Yield 0.5% 0.4% 0.5% 0.9% 1.2% 1.3% 0.5% 1.0% 1.0% 1.7% 2.2% 2.8% 3.1% 2.4% 2.6% 1.5% 1.0% 0.7% 1.6% 0.0% 0.00%
Net Buyback Yield 0.5% 0.4% 0.5% 0.9% 1.2% 1.3% 0.5% 1.0% 1.0% 1.7% 2.2% 2.8% 3.1% 2.4% 2.6% 1.5% 1.0% 0.7% 1.6% -0.0% -0.01%
Total Shareholder Return 0.6% 0.6% 0.7% 1.1% 1.5% 1.6% 0.7% 1.1% 1.2% 1.9% 2.4% 3.0% 3.4% 2.6% 3.0% 1.9% 1.3% 1.0% 1.9% 0.2% 0.23%
DuPont Factors
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 0.87 0.86 0.87 0.86 0.84 0.84 0.83 0.83 0.83 0.83 0.83 0.84 0.83 0.82 0.80 0.80 0.80 0.80 0.80 0.81 0.807
Interest Burden (EBT/EBIT) 1.02 1.02 1.02 1.01 1.01 1.02 1.02 1.02 1.01 1.01 1.01 1.01 1.02 1.02 1.02 1.02 1.02 1.02 1.02 1.01 1.015
EBIT Margin 0.26 0.27 0.27 0.27 0.26 0.24 0.23 0.22 0.23 0.24 0.23 0.21 0.21 0.20 0.20 0.20 0.20 0.20 0.21 0.21 0.207
Asset Turnover 0.94 0.93 0.95 0.93 0.90 0.83 0.82 0.81 0.83 0.79 0.80 0.80 0.77 0.77 0.80 0.80 0.78 0.78 0.83 0.83 0.829
Equity Multiplier 1.46 1.46 1.45 1.41 1.38 1.38 1.38 1.36 1.32 1.34 1.34 1.34 1.32 1.34 1.35 1.35 1.34 1.35 1.36 1.36 1.356
Per Share
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $8.06 $8.66 $9.01 $9.04 $8.33 $7.75 $7.29 $6.88 $7.43 $7.91 $7.65 $7.12 $6.81 $6.69 $6.40 $6.70 $6.76 $6.79 $7.50 $7.92 $7.92
Book Value/Share $28.98 $30.57 $30.61 $31.98 $32.64 $35.51 $36.67 $36.43 $38.09 $38.41 $36.08 $34.96 $37.49 $36.39 $36.75 $40.23 $41.97 $43.69 $41.30 $41.94 $42.23
Tangible Book/Share $27.20 $28.83 $28.89 $30.31 $31.03 $33.85 $35.01 $34.77 $36.46 $36.77 $34.44 $33.33 $35.84 $34.81 $35.15 $38.58 $40.33 $42.07 $39.70 $40.32 $40.32
Revenue/Share $35.29 $37.05 $37.89 $38.61 $38.40 $38.18 $38.08 $38.00 $38.86 $39.33 $39.42 $39.04 $39.19 $39.25 $39.67 $40.66 $41.50 $42.28 $44.48 $46.65 $46.98
FCF/Share $4.49 $4.33 $5.03 $5.30 $5.12 $5.81 $5.42 $5.26 $5.58 $5.53 $5.20 $4.85 $4.38 $3.75 $4.20 $4.73 $5.21 $6.45 $6.33 $6.13 $6.17
OCF/Share $7.53 $7.64 $8.51 $8.91 $8.64 $9.58 $9.39 $9.38 $10.20 $10.35 $10.18 $10.21 $9.57 $8.87 $9.10 $9.30 $9.54 $10.38 $9.88 $9.29 $9.35
Cash/Share $9.05 $9.98 $8.79 $9.48 $9.63 $11.83 $11.71 $10.56 $11.93 $11.39 $8.10 $6.05 $6.69 $6.58 $5.54 $7.00 $8.65 $10.88 $7.20 $6.11 $6.16
EBITDA/Share $10.61 $11.51 $11.75 $12.01 $11.44 $10.68 $10.31 $9.85 $10.63 $11.25 $10.99 $10.37 $10.14 $10.10 $10.01 $10.45 $10.62 $10.67 $11.65 $12.21 $12.21
Debt/Share $4.15 $4.26 $4.36 $4.39 $3.96 $4.21 $4.15 $4.13 $4.07 $4.12 $4.13 $4.22 $4.15 $4.14 $4.15 $4.17 $4.09 $5.73 $4.37 $4.38 $4.38
Net Debt/Share $-4.90 $-5.72 $-4.43 $-5.09 $-5.67 $-7.62 $-7.55 $-6.43 $-7.86 $-7.27 $-3.97 $-1.84 $-2.54 $-2.43 $-1.38 $-2.84 $-4.55 $-5.15 $-2.83 $-1.73 $-1.73
Academic Models
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — 17.445
Altman Z-Prime snapshot only 31.456
Piotroski F-Score 7 7 6 6 8 6 6 6 5 6 6 6 4 5 7 7 6 6 8 9 9
Beneish M-Score -2.19 -2.17 -2.32 -2.32 -2.47 -2.58 -2.64 -2.70 -2.77 -2.76 -2.73 -2.82 -2.59 -2.53 -2.64 -2.54 -2.60 -1.24 -3.71 -3.79 -3.790
Ohlson O-Score snapshot only -10.584
ROIC (Greenblatt) snapshot only 15.26%
Net-Net WC snapshot only $10.12
EVA snapshot only $258350143.92
Credit
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only AAA
Credit Score 94.00 93.73 94.07 95.24 94.57 96.27 95.48 95.65 95.62 95.58 95.53 95.67 95.50 95.25 94.76 95.31 95.12 95.11 94.88 95.68 95.683
Credit Grade snapshot only 1
Credit Trend snapshot only 0.369
Implied Spread (bps) snapshot only 50.000
Industry Credit Rank snapshot only 90
Sector Credit Rank snapshot only 92

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms